What are the diagnostic criteria for disseminated intravascular coagulation (DIC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for Disseminated Intravascular Coagulation (DIC)

Use the 2025 ISTH overt DIC scoring system, which requires a score ≥5 points based on platelet count, PT-INR, D-dimer, and fibrinogen levels in patients with an underlying condition known to cause DIC. 1

The 2025 ISTH Scoring System

The most recent update provides the following point allocation:

Laboratory Parameters:

  • Platelet count:

    • <100 × 10⁹/L = 1 point
    • <50 × 10⁹/L = 2 points
  • D-dimer elevation:

    • 3× upper limit of normal = 2 points

    • 7× upper limit of normal = 3 points

  • PT-INR prolongation:

    • <1.2 = 0 points
    • 1.2-1.4 = 1 point
    • 1.4 = 2 points

  • Fibrinogen:

    • 100 mg/dL = 0 points

    • <100 mg/dL = 1 point

A total score ≥5 points indicates overt DIC 1

Phase-Based Classification

The 2025 ISTH framework introduces three distinct phases 1:

  • Pre-DIC: Laboratory abnormalities without clinical symptoms
  • Early-phase DIC (non-overt): Subclinical or compensated DIC with laboratory changes preceding clinical manifestations
  • Overt DIC: Advanced stage with clear coagulopathy and organ failure

For sepsis-induced DIC specifically, the Sepsis-Induced Coagulopathy (SIC) score is now recognized as the appropriate tool for detecting early-phase DIC 1, 2. The Japanese guidelines recommend choosing diagnostic criteria based on understanding their specific diagnostic properties for different underlying conditions 2.

Essential Prerequisites

You must first identify an underlying condition known to cause DIC before applying any scoring system. Common triggers include:

  • Sepsis (most common)
  • Trauma with massive tissue injury
  • Malignancy
  • Obstetric complications
  • Severe organ destruction

Clinical Features to Recognize

The most suggestive clinical presentations are 3:

  • Bleeding (89% of cases): Oozing from venipuncture sites, mucosal bleeding, difficult-to-control hemorrhage
  • Petechiae (77%): Widespread microvascular bleeding manifestations
  • Shock (63%): From either hemorrhage or organ dysfunction

Disease-Specific Considerations

The 2025 criteria emphasize tailoring diagnosis to the underlying disease 1. For example:

  • Septic patients should use SIC scoring for early detection
  • Trauma patients may present with massive bleeding phenotype
  • Malignancy-associated DIC often shows thrombotic phenotype

Alternative Scoring Systems

While multiple systems exist (JAAM, JSTH, Korean Society criteria), only 28% of clinicians globally use formal scoring systems despite 76% reporting familiarity with ISTH definitions 3. The ISTH 2025 criteria represent the most current international consensus and should be prioritized.

Critical Pitfalls to Avoid

  • Do not diagnose DIC without an underlying causative condition - DIC is always secondary to another disease process
  • Serial monitoring is essential - DIC is a dynamic process requiring repeated laboratory assessment to track progression 3, 4
  • D-dimer standardization remains incomplete globally - the accuracy of the 2025 scoring depends on assay standardization not yet achieved 3
  • Single laboratory values are insufficient - no single test independently confirms DIC; the scoring system integrates multiple parameters 3

Phenotype Recognition

DIC manifests in two primary phenotypes that may coexist 1, 4:

  • Thrombotic DIC: Microvascular thrombosis with organ dysfunction predominates
  • Hemorrhagic DIC: Consumption coagulopathy with bleeding predominates

Recognizing the dominant phenotype guides management decisions beyond diagnosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.